Carol Lahiff is an experienced finance professional currently serving as Director at PepGen since June 2022, following a role as Associate Director, FP&A at Solid Biosciences. Previous experience includes contracting roles in FP&A at FORMA Therapeutics and Aegerion Pharmaceuticals, and a leadership position as Director of Revenue at Synageva BioPharma. Carol has held various finance positions at Genzyme, including Associate Director of Finance for the Transplant & Oncology Business Unit, where responsibilities included compliance with Sarbanes Oxley requirements and managing the US forecast/budget process. Earlier career experience includes a role as Credit Manager at Briggs NY. Carol holds a Bachelor of Science degree in Accounting from Bentley University.
This person is not in any teams
This person is not in any offices